SOLIGENIX, INC. — Director's Dealing 2009

Mar 16, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-03-11

Reporting Person: Hamilton Brian L (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-11	Stock Options (right to buy)	$.11	A	1000000	Acquired	2019-03-10	Common Stock (1000000)	Direct

Footnotes

F1: Granted stock options to purchase 1,000,000 shares of the Company?s common stock, of which 250,000 shares vest immediately and the remainder of the options will vest on each three (3) month anniversary of the grant date at a rate of 62,500 options per quarter. The exercise price of the options equals $0.11 per share, the market price of the Company?s common stock as of the close of business on March 11, 2009.